发明名称 |
Intranasal administration of glucose-regulating peptides |
摘要 |
Pharmaceutical compositions and methods are described comprising at least one glucose-regulating peptide, such as amylin, glucagon-like peptide-1 (GLP), pramlintide or exendin-4 and one or more mucosal delivery-enhancing agents for enhanced nasal mucosal delivery of the amylin, for treating a variety of diseases and conditions in mammalian subjects, including obesity and diabetes mellitus.
|
申请公布号 |
US2005143303(A1) |
申请公布日期 |
2005.06.30 |
申请号 |
US20040991597 |
申请日期 |
2004.11.18 |
申请人 |
NASTECH PHARMACEUTICAL COMPANY INC. |
发明人 |
QUAY STEVEN C.;COSTANTINO HENRY R. |
分类号 |
A61K9/00;A61K9/20;A61K38/12;A61K47/00;A61K47/10;A61K47/18;A61K47/24;(IPC1-7):A61K38/17;A61K38/22;A61K9/70 |
主分类号 |
A61K9/00 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|